ArticleCancer cell international2024

Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer.

Dongze Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.